Mobile game firm Scopely raises $200 million
Mobile game developer and publisher Scopely said on Tuesday it raised $200 million in its latest round of funding, a series D round, led by...
World unprepared for impact of climate change on mountain water supplies: experts
The world faces increased flooding, droughts and possible conflicts due to the effects of climate change on fresh water supplies drawn from mountains but is...
Oil vs Corn: U.S. lawmakers set hearing on fractious biofuels policy
The U.S. oil and corn industries will continue a long-running public battle over America’s biofuels policy on Tuesday during a Congressional hearing about the Trump...
Facebook, Google, Twitter urged to do more to combat fake news in EU
Facebook , Google and Twitter must do more to tackle fake news or face regulatory action, the European Commission said on Tuesday....
Lebanon PM Hariri likely to resign Tuesday: senior official source
Lebanon’s Prime Minister Saad al-Hariri will “most probably” announce his government’s resignation on Tuesday, a senior official source from outside Hariri’s bloc told Reuters....
Ex-California governor says Trump’s war on clean car rules ‘commercially suicidal’
The Trump administration’s rollback of U.S. clean car standards is “commercially suicidal” and will cost consumers billions of dollars, former California Governor Jerry Brown will...
ConocoPhillips profit slumps 43% on lower oil prices, higher costs
ConocoPhillips reported a 43% drop in adjusted quarterly profit on Tuesday, dragged by lower crude prices and higher exploration expenses....
Poll: Who’s sticking with President Trump, through trouble and tweets? His seemingly unshakable base. – USA TODAY
Poll: Who’s sticking with President Trump, through trouble and tweets? His seemingly unshakable base. USA TODAY Pelosi says House will vote this week on resolution formalizing...
Pfizer beats profit estimates, raises 2019 earnings forecast
Pfizer Inc posted a third-quarter profit well ahead of analysts’ estimates on higher sales of breast cancer drug Ibrance and raised its earnings forecast for...
Merck profit beats estimates as Keytruda sales surge
Merck & Co Inc reported a better-than-expected quarterly profit on Tuesday and raised its full-year earnings forecast as sales of its blockbuster immunotherapy, Keytruda, crossed...
